Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator
Open Access
- 8 January 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (2), 462-469
- https://doi.org/10.1182/blood-2008-05-155952
Abstract
Curcumin is a natural product currently in human clinical trials for a variety of neoplastic, preneoplastic, and inflammatory conditions. We previously observed that, in cultured cells, curcumin exhibits properties of an iron chelator. To test whether the chelator activity of curcumin is sufficient to induce iron deficiency in vivo, mice were placed on diets containing graded concentrations of both iron and curcumin for 26 weeks. Mice receiving the lowest level of dietary iron exhibited borderline iron deficiency, with reductions in spleen and liver iron, but little effect on hemoglobin, hematocrit, transferrin saturation, or plasma iron. Against this backdrop of subclinical iron deficiency, curcumin exerted profound 2 effects on systemic iron, inducing a dose-dependent decline in hematocrit, hemoglobin, serum iron, and transferrin saturation, the appearance of microcytic anisocytotic red blood cells, and decreases in spleen and liver iron content. Curcumin repressed synthesis of hepcidin, a peptide that plays a central role in regulation of systemic iron balance. These results demonstrate that curcumin has the potential to affect systemic iron metabolism, particularly in a setting of subclinical iron deficiency. This may affect the use of curcumin in patients with marginal iron stores or those exhibiting the anemia of cancer and chronic disease.This publication has 58 references indexed in Scilit:
- Mapping genes responsible for strain-specific iron phenotypes in murine chromosome substitution strainsBlood Cells, Molecules, and Diseases, 2007
- Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balanceJCI Insight, 2007
- Curcumin reduces indomethacin‐induced damage in the rat small intestineJournal of Applied Toxicology, 2007
- Curcumin [1,7-Bis(4-hydroxy-3-methoxyphenyl)-1–6-heptadine-3,5-dione; C21H20O6] Sensitizes Human Prostate Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand/Apo2L-Induced Apoptosis by Suppressing Nuclear Factor-κB via Inhibition of the Prosurvival Akt Signaling PathwayThe Journal of pharmacology and experimental therapeutics, 2007
- A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeuticsProceedings of the National Academy of Sciences of the United States of America, 2006
- Molecular control of vertebrate iron homeostasis by iron regulatory proteinsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2006
- Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelinBlood, 2005
- Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liverThe International Journal of Biochemistry & Cell Biology, 1998
- Chemoprevention and therapy of mouse mammary carcinomas with doxorubicin encapsulated in sterically stabilized liposomesCancer, 1994
- Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss miceNutrition and Cancer, 1992